Hva betyr "Tøm"?
Dyret bærer ikke mutasjonen. Det vil ikke utvikle sykdommen og vil ikke gi det videre.
Hund Neuronal Ceroid Lipofuscinosis 6 hos Australian Shepherd (NCL6-AS)
Discover the importance of DNA testing for Neuronal Ceroid Lipofuscinosis 6 (NCL6) in Australian Shepherds. NCL6 is a hereditary neurological disorder that can severely impact your dog's quality of life. Early detection through a simple DNA test allows for proactive care and informed breeding decisions. By identifying carriers and affected dogs, breeders can significantly reduce the risk of this debilitating condition. Ensure your Australian Shepherd remains healthy and vibrant by prioritizing genetic testing for NCL6. Protect your furry friend and make educated choices for their future. Invest in a DNA test today to safeguard your dog's health!
Forkortelse: NCL6-AS
Analysert mutasjon: CLN6 c.829T>C
Arv: Autosomal recessiv
Akronym
NCL6-AS
Observert frekvens
Klinisk alvorlighetsgrad
Klinisk klassifisering
Nevrologiske sykdommer
Analysert mutasjon
CLN6 c.829T>C
p.(W277R)
p.(W277R)
Metode for arv
Autosomal recessiv (Fullstendig)
Testsammendrag:
Neuronal Ceroid Lipofuscinosis 6 (NCL6) is a genetic disorder affecting Australian Shepherds, leading to progressive neurological decline. This condition is caused by mutations in the CLN6 gene, resulting in the accumulation of lipofuscin in neurons. Early symptoms often include vision problems, seizures, and behavioral changes. A DNA test is available to identify carriers and affected dogs, allowing for informed breeding decisions. Responsible testing can help reduce the incidence of NCL6 in this beloved breed.
Tilgjengelig fra pakken: Basic
Denne DNA-testen er inkludert fra pakken vår Basic — og er også en del av pakkene Basic, Standard, Advanced, Complete.
Se DNA-testpakker →Velg pakken som passer best til din avl eller helsestrategi for dyrene dine.
Understanding Neuronal Ceroid Lipofuscinosis 6 (NCL6)
Neuronal Ceroid Lipofuscinosis 6 (NCL6) is a progressive neurodegenerative disorder that affects the central nervous system of dogs, particularly impacting the functioning of neurons. This condition is characterized by the accumulation of lipopigments, which are fatty substances that build up in the brain and other tissues. The accumulation leads to cellular dysfunction and eventually cell death, resulting in a range of neurological symptoms.
Symptoms of NCL6
The clinical signs of NCL6 often manifest in young dogs, typically between the ages of 6 months to 2 years. Common symptoms include progressive vision loss due to retinal degeneration, seizures, loss of coordination, behavioral changes, and cognitive decline. As the disease advances, affected dogs may experience difficulty with movement, muscle tremors, and an overall decline in quality of life.
Genetic Basis of NCL6
NCL6 is caused by mutations in the CLN6 gene, which plays a crucial role in cellular function, particularly in the maintenance of lysosomal function. The inheritance pattern of this condition is autosomal recessive, meaning that both copies of the mutated gene must be present for the disease to manifest. Breeding practices that identify and eliminate carriers of this mutation are essential in preventing the condition from being passed on to future generations.
Viktigheten av DNA-testing
DNA testing for NCL6 is crucial for responsible breeding practices. By identifying carriers of the CLN6 mutation, breeders can make informed decisions to avoid producing affected puppies. This proactive approach helps to manage the prevalence of NCL6 within the breed, ultimately contributing to the health and longevity of future generations of dogs.
Managing a Dog with NCL6
While there is currently no cure for NCL6, supportive care can help manage the symptoms and improve the quality of life for affected dogs. This may include a balanced diet, physical therapy, and medications to control seizures and other symptoms. Regular veterinary check-ups are essential to monitor the progression of the disease and make any necessary adjustments to the care plan.
Konklusjon
Neuronal Ceroid Lipofuscinosis 6 (NCL6) is a serious genetic disorder that poses significant challenges for affected dogs and their owners. Through DNA testing and responsible breeding practices, it is possible to reduce the incidence of this condition, ensuring healthier futures for dogs at risk. Awareness, early diagnosis, and management strategies are vital for supporting dogs diagnosed with NCL6.
Rase anerkjent for testen: Neuronal Ceroid Lipofuscinosis 6 hos Australian Shepherd (NCL6-AS)
- Aussiedoodle
- Australian Shepherd
- Miniature American Shepherd
- Miniature Australian Shepherd Dog
- Toy Australian Shepherd Dog
🧬 Interpretation of genotypes NCL6-AS
Genotype
Status
🟡 N/N
Ikke-transportør - Ingen risiko
🟡 N/NCL6-AS
Transportør - Ingen risiko
❌ NCL6-AS/NCL6-AS
Berørt - i faresonen
FAQ: forstå tolkningen
Er en "Carrier" seriøs?
Nei. Dyret er generelt sunt, men kan overføre mutasjonen til dens avkom.
Hva om et dyr er "påvirket"?
Den har to muterte kopier. Kliniske tegn forventes avhengig av sykdommen. Det skal ikke avles.
Hvorfor er det forskjeller mellom mann og kvinne?
Noen sykdommer er kjønnsbundne, så uttrykket deres varierer avhengig av dyrs kjønn.
Forutsi avkom
N/N (ikke-transportor)
N/NCL6-AS (Transportør)
NCL6-AS/NCL6-AS (Berørt)
Vanlige spørsmål om DNA-test
Hva oppdager denne DNA-testen?
This DNA test detects the mutation associated with Neuronal Ceroid Lipofuscinosis 6 In Australian Shepherd (NCL6) in order to identify clear, carrier, or at-risk animals.
Hvorfor teste et avlsdyr?
DNA-testing hjelper oppdrettere med å planlegge sikrere parringer og redusere risikoen for å overføre mutasjonen til avkom.
Hva er arvemodusen for denne testen?
Arvemodusen som er rapportert for denne testen er autosomal recessiv.
Hvilken mutasjon analyseres i denne testen?
This test analyses the mutation CLN6 c.829T>C.
Er et bærerdyr nødvendigvis påvirket?
Ikke nødvendigvis. Tolkning avhenger av arvemønsteret og den resulterende genotypen.
Referanser
Katz Martin L, Farias Fabiana H, Sanders Douglas N, Zeng Rong, Khan Shahnawaz, Johnson Gary S, O'Brien Dennis P. A missense mutation in canine CLN6 in an Australian shepherd with neuronal ceroid lipofuscinosis. J Biomed Biotechnol. 2011;2011:198042. doi: 10.1155/2011/198042. Epub 2010 Dec 22.